On May 28, CITIC Securities announced that Yuan Qinghui officially assumed the role of head of the pharmaceutical and healthcare research team at CITIC Securities. Yuan Qinghui has a combined background in industrial R&D and industry research, having previously worked on the development of new drugs for Alzheimer’s and oncology, and specializes in research on the innovative drug industry.
